Hunan Er Kang Pharmaceutical (300267) — Capital Reinvestment Ratio
Hunan Er Kang Pharmaceutical (300267) has a Capital Reinvestment Ratio of 0.26x as of June 2023, meaning it reinvests 0% of its operating cash flow (CN¥174.55 Million) in capital expenditures (CN¥45.68 Million). See 300267 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hunan Er Kang Pharmaceutical Capital Reinvestment Ratio (2008–2024)
This chart tracks Hunan Er Kang Pharmaceutical's Capital Reinvestment Ratio across 17 annual periods. Check how aggressively does Hunan Er Kang Pharmaceutical reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hunan Er Kang Pharmaceutical (2008–2024)
Year-by-year Capital Reinvestment Ratio for Hunan Er Kang Pharmaceutical from 2008 to 2024. For live market cap and broader valuation context, see Hunan Er Kang Pharmaceutical market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.17x | CN¥166.69 Million | CN¥195.60 Million | ▼ -26.9% |
| 2023 | 1.60x | CN¥148.42 Million | CN¥238.19 Million | ▲ +159.9% |
| 2022 | 0.62x | CN¥281.02 Million | CN¥173.49 Million | ▼ -83.6% |
| 2021 | 3.77x | CN¥92.68 Million | CN¥349.33 Million | ▲ +11.1% |
| 2020 | 3.39x | CN¥178.53 Million | CN¥605.89 Million | ▲ +315.4% |
| 2019 | 0.82x | CN¥445.82 Million | CN¥364.21 Million | ▲ +4.6% |
| 2018 | 0.78x | CN¥123.89 Million | CN¥96.72 Million | ▲ +107.8% |
| 2017 | 0.38x | CN¥689.11 Million | CN¥258.92 Million | ▼ -84.0% |
| 2016 | 2.36x | CN¥486.50 Million | CN¥1.15 Billion | ▲ +114.2% |
| 2015 | 1.10x | CN¥518.96 Million | CN¥570.53 Million | ▼ -63.4% |
| 2014 | 3.01x | CN¥175.38 Million | CN¥527.42 Million | ▲ +156.9% |
| 2013 | 1.17x | CN¥174.22 Million | CN¥203.98 Million | ▼ -57.5% |
| 2012 | 2.75x | CN¥84.02 Million | CN¥231.28 Million | ▲ +375.1% |
| 2011 | 0.58x | CN¥75.72 Million | CN¥43.87 Million | ▼ -62.2% |
| 2010 | 1.53x | CN¥42.47 Million | CN¥65.05 Million | ▼ -20.6% |
| 2009 | 1.93x | CN¥10.18 Million | CN¥19.64 Million | ▼ -96.8% |
| 2008 | 59.81x | CN¥211.00K | CN¥12.62 Million | — |